NeuroSense Therapeutics Ltd.
NRSN
$1.14
-$0.0301-2.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.35M | -2.35M | -- | -- | -- |
| Total Depreciation and Amortization | 4.00K | 4.00K | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 153.00K | 153.00K | -- | -- | -- |
| Change in Net Operating Assets | 197.50K | 197.50K | -- | -- | -- |
| Cash from Operations | -2.00M | -2.00M | -- | -- | -- |
| Capital Expenditure | -2.50K | -2.50K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.00K | -4.00K | -- | -- | -- |
| Cash from Investing | -6.50K | -6.50K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 683.00K | 683.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -32.50K | -32.50K | -- | -- | -- |
| Cash from Financing | 650.50K | 650.50K | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.36M | -1.36M | -- | -- | -- |